Cytokines Required for Induction of Histocompatibility Leukocyte Antigen-class I-restricted and Tumor-specific Cytotoxic T Lymphocytes by a SART1-derived Peptide
スポンサーリンク
概要
- 論文の詳細を見る
- 1999-09-30
著者
-
ITOH Kyogo
Cancer Vaccine Development Division, Kurume University Research Center for Innovative Cancer Therapy
-
Itoh K
Kurume Univ. School Of Medicine Fukuoka
-
Itoh Kyogo
久留米大学 医学部免疫学
-
Imaizumi Toshihiro
Cancer Vaccine Development Division Of Kurume University Research Center For Innovative Cancer Thera
-
Itoh K
Kurume Univ. School Of Medicine Fukuoka Jpn
-
MATSUNAGA Kazuko
Cancer Vaccine Development Division of Kurume University Research Center for Innovative Cancer Thera
-
NAKAO Masanobu
Cancer Vaccine Development Division of Kurume University Research Center for Innovative Cancer Thera
-
MASUOKA Kazuhiro
Immunology, Kurume University School of Medicine
-
INOUE Yoshiko
Cancer Vaccine Development Division of Kurume University Research Center for Innovative Cancer Thera
-
GOUHARA Rumi
Immunology, Kurume University School of Medicine
-
NISHIZAKA Shinya
Cancer Vaccine Development Division of Kurume University Research Center for Innovative Cancer Thera
-
Itoh K
Cancer Vaccine Development Division Kurume University Research Center For Innovative Cancer Therapy
-
Itoh K
Departments Of Immunology Kurume University School Of Medicine
-
Itoh Kyogo
Department Of Lmmunology Kurume University School Of Medicine
-
NISHIZAKA Shinya
Departments of Immunology, Kurume University School of Medicine
-
MATSUNAGA Kazuko
Departments of Immunology, Kurume University School of Medicine
-
Itoh Kyogo
Cancer Vaccine Development Division Kurume University Research Center For Innovative Cancer Therapy
-
Itoh Kyogo
Cancer Vaccine Development Division Research Center For Innovative Cancer Therapy Kurume University
-
Nakao Masanobu
Cancer Vaccine Development Division Of Kurume University Research Center For Innovative Cancer Thera
-
Matsunaga Kazuko
Departments Of Immunology Kurume University School Of Medicine
-
Gouhara R
Kurume Univ. School Of Medicine
-
Nishizaka Shinya
Departments Of Immunology Kurume University School Of Medicine
-
Gouhara Rumi
Immunology Kurume University School Of Medicine
-
Inoue Yoshiko
Cancer Vaccine Development Division Of Kurume University Research Center For Innovative Cancer Thera
関連論文
- Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b^+ HLA-A24^+ patients
- New Epitope Peptides Derived from Hepatitis C Virus (HCV) 2a Which Have the Capacity to Induce Cytotoxic T Lymphocytes in HLA-A2^+ HCV-Infected Patients
- Phase I trial of patient-oriented vaccination in HLA-A2-positive patients with metastatic hormone-refractory prostate cancer
- Cytokines Required for Induction of Histocompatibility Leukocyte Antigen-class I-restricted and Tumor-specific Cytotoxic T Lymphocytes by a SART1-derived Peptide
- Sequence Analysis of Genes Encoding Rodent Homologues of the Human Tumor-rejection Antigen SART-1
- Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer
- Expression of Tumor-rejection Antigens in Gynecologic Cancers
- Expression of the SART-1 Antigens in Uterine Cancers
- Target molecules in specific immunotherapy against prostate cancer
- Identification of a prostate-specific membrane antigen-derived peptide capable of eliciting both cellular and humoral immune responses in HLA-A24^+ prostate cancer patients
- Histocompatibility Leukocyte Antigen-A2-restricted and Tumor-specific Cytotoxic T Lymphocytes from Tumor-infiltrating Lymphocytes of a Patient with Testicular Embryonal Cancer
- Expression of MAGE-1 Gene by Esophageal Carcinomas
- Expression of SART3 Tumor-rejection Antigen in Gastric Cancers
- Phase I trial of personalized peptide vaccination for cytokine-refractory metastatic renal cell carcinoma patients
- Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy
- Antibody Reactive to a Hepatitis C Virus (HCV)-Derived Peptide Capable of Inducing HLA-A2 Restricted Cytotoxic T Lymphocytes Is Detectable in a Majority of HCV-Infected Individuals without HLA-A2 Restriction
- Chemohormonal therapy as primary treatment for metastatic prostate cancer : A randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist
- Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide
- Immunological evaluation of CTL precursor-oriented vaccines for advanced lung cancer patients
- Serine Proteinase Inhibitor 9 Can Be Recognized by Cytotoxic T Lymphocytes of Epithelial Cancer Patients
- Identification of Cyclophilin B-derived Peptides Capable of Inducing Histocompatibility Leukocyte Antigen-A2-restricted and Tumor-specific Cytotoxic T Lymphocytes
- Mouse Homologue of the Human SART3 Gene Encoding Tumor-rejection Antigen
- Detection of Circulating Tumor Cells in Patients with Prostate Cancer Using Prostate Specific Membrane-Derived Primers in the Polymerase Chain Reaction
- A GENE ENCODING SQUAMOUS CELL CARCINOMA ANTIGENS RECOGNIZED BY CYTOTOXIC T LYMPHOCYTE
- Genes Encoding Antigenic Peptides of Human Epithelial Cancers Recognized by Cytotoxic T Lymphocytes
- Detection of MAGE-4 Protein in Sera of Lung Cancer Patients
- Human Tumor Rejection Antigens MAGE1^1
- Cytokine Production by T Cells Infiltrating in the Eye of Uveitis Patients
- Induction of MAGE Genes in Lymphoid Cells by the Demethylating Agent 5-Aza-2'-deoxycytidine
- In Vitro Effects of Immunosuppressive Agents on Cytokine Production by HTLV-I-Infected T Cell Clones Derived from the Ocular Fluid of Patients with HTLV-I Uveitis
- Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanona antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease
- High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma
- Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2^+ glioma patients
- Elevation of Serum MAGE-4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis
- Detection of MAGE-4 Protein in the Sera of Patients with Hepatitis-C Virus-associated Hepatocellular Carcinoma and Liver Cirrhosis
- Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles
- Identification of peptides applicable as vaccines for HLA-A26-positive cancer patients
- Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection
- Evaluation of a new oil adjuvant for use in peptide-based cancer vaccination
- Exploring immune therapy for renal cancer